Ads
related to: stok- Our Products
Recharge Your Way With Cold
Brew or Caffeine Coffee Shots
- Find Your Cold Brew
Greatness is Close. Find STōK®
Cold-Brew Coffee Near You
- STōK® Cold Brew Coffee
Made to Fuel Your Passions
Find Your Cold-Brew Coffee Flavor
- How We Do Cold-Brew
We Are Method-Obsessed
We Use Time And Patience, Not Heat
- Our Products
Search results
Should You Buy Stoke Therapeutics, Inc. (STOK) After Golden Cross?
Zacks via Yahoo Finance· 11 months agoStoke Therapeutics, Inc. (STOK) is looking like an interesting pick from a technical perspective, as...
Does Stoke Therapeutics, Inc. (STOK) Have the Potential to Rally 284.14% as Wall Street Analysts...
Zacks via Yahoo Finance· 3 months agoThe mean of analysts' price targets for Stoke Therapeutics, Inc. (STOK) points to a 284.1% upside in...
Racecourse Ground refreshed as Wrexham partner with US cold brew coffee brand
PA Media: Sport via Yahoo Sports· 12 months agoWrexham’s historic Racecourse Ground will become known as the SToK Racecourse under the terms of a...
Stoke Therapeutics Inc (STOK) Reports Q3 Financial Results and Progress in Dravet Syndrome Treatment
GuruFocus.com via Yahoo Finance· 6 months agoStoke Therapeutics Inc (NASDAQ:STOK) anticipates Q1 2024 readout for Phase 1/2a study results of...
Stoke Therapeutics, Inc. (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks via Yahoo Finance· 2 years agoAfter losing some value lately, a hammer chart pattern has been formed for Stoke Therapeutics, Inc....
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
Zacks via Yahoo Finance· 2 months agoStoke Therapeutics, Inc. STOK reported encouraging new data from two phase I/IIa studies and two...
Earnings Update: Stoke Therapeutics, Inc. (NASDAQ:STOK) Just Reported And Analysts Are Boosting...
Simply Wall St. via Yahoo Finance· 1 year agoStoke Therapeutics, Inc. (NASDAQ:STOK) defied analyst predictions to release its first-quarter...
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoStoke Therapeutics, Inc. (STOK) delivered earnings and revenue surprises of 4.35% and 2.07%,...
Stoke Therapeutics (NASDAQ:STOK) adds US$56m to market cap in the past 7 days, though investors from...
Simply Wall St. via Yahoo Finance· 2 years agoIt's nice to see the Stoke Therapeutics, Inc. (NASDAQ:STOK) share price up 12% in a week. But that...
Investors in Stoke Therapeutics (NASDAQ:STOK) have unfortunately lost 64% over the last three years
Simply Wall St. via Yahoo Finance· 1 year agoIf you love investing in stocks you're bound to buy some losers. But the last three years have been...
Ad
related to: stok